|
|
|
|
|
|
GMMMG Approved Shared Care Protocols |
|
|
On this page you will find all shared care protocols (SCPs) that have been approved by GMMMG for use across Greater Manchester. As we move to a single GM commissioning arrangement, SCPs will be annotated to better define commissioning arrangements. The GMMMG agreed process for transfer of prescribing responsibilities can be found here. The shared care protocol template includes a section for requesting shared care and letter templates to respond to the shared care request. Following local adaptation, GMMMG will adopt SCPs produced by the Regional Medicines Optimisation Committee (RMOC), as part of the “Shared Care for Medicines Guidance – a Standard Approach”. GMMMG will continue the development of SCPs which are outside the published RMOC schedule but have been identified as required by the GMMMG system as shared care medicines. Any SCPs listed below which have passed their review date will remain in use until an updated GMMMG approved version is available, with only technical updates to address any emerging safety issues. The responsibility for the production and updating of SCPs lies with the originating author in collaboration with the GMMMG Clinical Reference Group. Enquiries regarding the development of SCPs can be submitted to nuth.enquires@gmmmg.nhs.net. |
||
(C) = BNF for children
The ‘Drug’, ‘BNF’ and ‘Review date’ headings below are active links. Click a heading to sort in ascending or descending order.
|
|
|
|
|
|
|
|
|
|
|
|
Document title |
Issue date |
Comments |
|||
|
|
|
Adult ADHD |
Atomoxetine, Dexamfetamine, Guanfacine, Lisdexamfetamine and Methylphenidate for ADHD in Adults |
4 |
Jan 2020 |
Oct 2022 |
|
|
|
|
Antipsychotics |
4 |
Jan 2018 |
May 2018 |
update in progress |
|
|
|
|
Antipsychotics |
Antipsychotics for Bipolar Disorder in children and adolescents |
4 |
Oct 2017 |
Oct 2020 |
|
|
|
|
Antipsychotics |
Antipsychotics for the treatment of OCD in children and adolescents |
4 |
Oct 2017 |
Oct 2020 |
|
|
|
|
Antipsychotics |
Antipsychotics for Psychosis and Schizophrenia in children and adolescents |
4 |
Oct 2017 |
Oct 2020 |
|
|
|
|
Antipyschotics |
4 |
Sep 2017 |
Apr 2018 |
update in progress |
|
|
|
|
Apomorphine |
4 |
Dec 2018 |
Dec 2021 |
|
|
|
|
|
Aripiprazole |
4 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
Atomoxetime |
4 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
Azathioprine |
1 |
Sep 2017 |
May 2018 |
|
|
|
|
|
Azathioprine |
Azathioprine and 6-Mercaptopurine for the treatment of IBD in Adults |
1 |
Nov 2017 |
Oct 2020 |
|
|
|
|
Azathioprine |
10 |
Nov 2017 |
Oct 2020 |
|
|
|
|
|
Azathioprine |
13 |
Feb 2018 |
Feb 2021 |
|
|
|
|
|
Azathioprine |
8 |
Jul 2018 |
Jul 2021 |
|
|
|
|
|
Azathioprine |
3 |
Oct 2018 |
Oct 2021 |
|
|
|
|
|
Azathioprine |
1 |
Nov 2019 |
Nov 2022 |
|
|
|
|
|
Ciclosporin |
10 |
Jan 2018 |
Oct 2020 |
|
|
|
|
|
Ciclosporin |
13 |
Feb 2018 |
Feb 2021 |
|
|
|
|
|
Cinacalcet |
9 |
Jun 2017 |
Jun 2020 |
|
|
|
|
|
Colistimethate |
Nebulised Colistimethate in adult patients with non-CF bronchiectasis or bronchial sepsis |
5 |
Sep 2017 |
Jun 2020 |
|
|
|
|
Degarelix |
Degarelix in advanced hormone dependent prostate cancer in Adults |
7 |
Sep 2017 |
Jun 2020 |
|
|
|
|
Denosumab |
6 |
Nov 2017 |
Oct 2020 |
|
|
|
|
|
Dexamfetamine |
4 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
Disulfiram |
4 |
Aug 2018 |
Aug 2021 |
|
|
|
|
|
Domperidone |
Domperidone for Paediatric Gastro-oesophageal Reflux Disease (GORD) |
1 |
Aug 2018 |
Aug 2021 |
|
|
|
|
Estradiol |
Feminising hormones for patients aged 17 years or over under Indigo Gender Service |
6 |
Mar 2021 |
Mar 2024 |
|
|
|
|
Ethinylestradiol |
6 |
Dec 2017 |
Dec 2020 |
|
|
|
|
|
Goserelin |
8 |
Oct 2018 |
Oct 2021 |
|
|
|
|
|
Goserelin/Leuprorelin/Triptorelin |
GnRH analogues for patients aged 17 years or over under Indigo Gender Service |
6 |
Mar 2021 |
Mar 2024 |
|
|
|
|
Growth hormone |
6 |
Mar 2020 |
Mar 2023 |
|
|
|
|
|
Guanfacine |
4 |
Sep 2017 |
Nov 2019 |
|
|
|
|
|
Hydroxycarbamide |
9 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
Hydroxycarbamide |
9 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
Hydroxychloroquine |
13 |
Feb 2018 |
Apr 2022 |
|
|
|
|
|
Hydroxychloroquine |
10 |
Nov 2017 |
Apr 2022 |
|
|
|
|
|
Ibandronate |
6 |
Sep 2017 |
Jun 2020 |
|
|
|
|
|
Leflunomide |
10 |
Nov 2017 |
Oct 2020 |
|
|
|
|
|
LHRH Analogues |
7 |
Sep 2017 |
Apr 2020 |
|
|
|
|
|
Lisdexamfetamine |
4 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
Lithium |
Lithium for patients over 18 years old including those aged 65 years and older |
4 |
Dec 2017 |
Dec 2020 |
|
|
|
|
Melatonin |
4 |
Sep 2017 |
Feb 2020 |
|
|
|
|
|
Methotrexate |
3 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
Methotrexate |
10 |
Nov 2017 |
Oct 2020 |
|
|
|
|
|
Methotrexate |
13 |
Jul 2018 |
Jul 2021 |
|
|
|
|
|
Methotrexate |
1 |
Oct 2018 |
Oct 2021 |
|
|
|
|
|
Methylphenidate |
4 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
Mycophenolate |
3 |
Sep 2017 |
Nov 2019 |
|
|
|
|
|
Mycophenolate |
Mycophenolate Mofetil for Rheumatological Conditions in Adults |
10 |
Nov 2017 |
Oct 2020 |
|
|
|
|
Mycophenolate |
13 |
Feb 2018 |
Feb 2021 |
|
|
|
|
|
Paliperidone |
4 |
Nov 2019 |
Nov 2022 |
|
|
|
|
|
Penicillamine |
Penicillamine for the treatment of rheumatoid arthritis or Wilson’s disease in adults |
Misc |
Jan 2020 |
Jan 2023 |
|
|
|
|
Riluzole |
Riluzole for Amyotrophic Lateral Sclerosis (a form of Motor Neurone Disease) |
4 |
Nov 2019 |
Nov 2022 |
|
|
|
|
Risperidone |
4 |
Aug 2017 |
Aug 2020 |
|
|
|
|
|
SSRIs |
SSRIs for the treatment of Anxiety Disorders in children and adolescents |
4 |
Oct 2017 |
Oct 2020 |
|
|
|
|
SSRIs |
SSRIs for the treatment of Depression in children and adolescents |
4 |
Oct 2017 |
Oct 2020 |
|
|
|
|
SSRIs |
SSRIs for the treatment of OCD and Body Dysmorphic Disorder (BDD) in children and adolescents |
4 |
Oct 2017 |
Oct 2020 |
|
|
|
|
Sulfasalazine |
10 |
Nov 2017 |
Oct 2020 |
|
|
|
|
|
Sulfasalazine |
1 |
Aug 2018 |
Aug 2021 |
|
|
|
|
|
Testosterone |
Masculinising hormones for patients aged 17 years or over under Indigo Gender Service |
6 |
Mar 2021 |
Mar 2024 |
|
|
|
|
|
|
|
|
|
|
<< Back
